BPC-157 10mg · Research brief
Peptide Impurities Types: Where They Come From
Short answer
A vial certified at 98% purity by HPLC can still be less than 80% peptide by mass. Those two figures measure different things, and the gap between them is filled by counterions, bound water, and residual solvents that never register as a peak at 214 nm.
Key takeaways
- Peptide impurities types divide into process-related species from synthesis, product-related degradants from storage, and non-peptide residues such as counterions, solvents and endotoxin.
- HPLC purity measured at 214 nm and net peptide content are different numbers, and net peptide content for TFA-salt lyophilisates is commonly reported in roughly the 70-90% range.
- Trifluoroacetate counterion load scales with the number of basic residues, so an arginine-rich sequence carries more non-peptide mass than a neutral one at identical purity.
- Deletion sequences are the hardest peptide impurities types to remove because they co-elute closely with the target molecule.
- Methionine oxidation at +16 Da and asparagine deamidation at +1 Da are the two degradation signatures most worth checking on a mass spectrum.
- ICH Q3C classifies acetonitrile, DMF and DCM as Class 2 residual solvents with defined limits, measured by headspace gas chromatography.
- Endotoxin contributes nothing to a chromatogram and is quantified separately by LAL assay, which matters most in cell-based research.
A vial certified at 98% purity by HPLC can still be less than 80% peptide by mass. Those two figures measure different things, and the gap between them is filled by counterions, bound water, and residual solvents that never register as a peak at 214 nm.
Our team reads chromatograms alongside the researchers who order from us, and one question surfaces more than any other: what is that small peak eluting just ahead of the main one? It almost always has a name, a mechanism, and a traceable point of origin in the synthesis.
What are the main peptide impurities types?
Peptide impurities types sort into three families: process-related impurities generated during synthesis (deletion, truncation and insertion sequences, incomplete deprotection, aspartimide formation), product-related degradants that form later (oxidation, deamidation, hydrolysis, aggregation), and non-peptide residues (trifluoroacetate or acetate counterions, residual solvents, water, endotoxin). Each family has a different origin and requires a different analytical test.
The oversimplification worth killing early is the idea that purity is one number. A chromatographic purity figure describes the peptide-related fraction of what a UV detector sees at 214 nm. It says nothing about how much of the vial's mass is peptide at all, and nothing about species that do not absorb there. What follows covers the peptide impurities types built during solid-phase synthesis, the non-peptide residues that survive purification, and the degradants that appear during storage.
Deletion, truncation, and everything else synthesis leaves behind
Process-related peptide impurities types are structural cousins of the target sequence, created whenever a step in solid-phase peptide synthesis (SPPS) runs at less than 100% efficiency. Across a 30-residue sequence with dozens of coupling and deprotection cycles, small per-cycle inefficiencies compound into a whole family of related molecules.
Deletion sequences form when a coupling step fails at a single cycle and the chain continues without that residue. The product is missing one internal amino acid, differs from the target by exactly that residue's mass, and frequently elutes close enough to the main peak to appear only as a shoulder. Truncated sequences come from capping, where unreacted chains are deliberately acetylated so they stop growing, producing shorter fragments that usually resolve earlier in a reversed-phase gradient. Insertion sequences are the mirror image: one residue coupled twice.
Incomplete deprotection is the category researchers underestimate. Side-chain protecting groups such as Pbf on arginine, tBu on serine, threonine and tyrosine, and Trt on cysteine and asparagine all have to come off during acid cleavage, and the SPPS literature consistently describes Pbf removal from arginine-rich sequences as slow and often incomplete. The result is a mass-shifted species that is chemically identical everywhere else.
Two more deserve names. Aspartimide formation, described in the literature as most aggressive at Asp-Gly motifs under repeated piperidine exposure, yields beta-aspartyl peptides and D-epimers. Racemization at cysteine and histidine during activation does something similar with no mass change at all. Flagging aspartimide-prone sequences at synthesis planning, rather than at analysis, is the correct order.
Why a 98% chromatogram can still be one-fifth non-peptide
Chromatographic purity and peptide content are independent measurements, and the second one is where entire categories of peptide impurities types hide. Reversed-phase purification almost universally uses trifluoroacetic acid (TFA) as an ion-pairing modifier, so the lyophilized powder that reaches the vial is a TFA salt.
Here is the mechanism most purity discussions skip. Trifluoroacetate pairs with basic sites, meaning arginine, lysine and histidine residues plus the free N-terminus. Counterion load therefore scales with how many basic residues a sequence contains. Two peptides of identical length and identical 98% HPLC purity can differ substantially in net peptide content simply because one is arginine-rich and the other is not. Net peptide content for TFA-salt lyophilisates is commonly reported in roughly the 70-90% range, and it is determined by amino acid analysis or nitrogen determination, never by HPLC.
Water is the second silent mass. Lyophilized peptides are hygroscopic, and Karl Fischer titration is the standard method for quantifying residual moisture.
Residual solvents are the third. Acetonitrile, dimethylformamide (DMF), dichloromethane (DCM) and diethyl ether all appear across synthesis and purification workflows. ICH Q3C classifies acetonitrile, DMF and DCM as Class 2 solvents with defined limits, while ethanol and acetic acid fall into lower-concern Class 3. Headspace gas chromatography is the analysis that finds them.
Endotoxin rounds out the group. Bacterial endotoxin is not peptide-related, contributes nothing to a chromatogram, and is measured separately by LAL (Limulus amebocyte lysate) assay. For cell-based research it matters considerably more than the final half-percent of chromatographic purity.
Degradants: the impurities that appear after the certificate was written
Not every impurity exists at the moment of testing. Product-related peptide impurities types accumulate after release, driven by oxygen, moisture, temperature and pH.
Oxidation is the most common. Methionine converts to methionine sulfoxide with a +16 Da mass shift that is unmistakable on LC-MS, and cysteine, tryptophan and histidine are also oxidation-sensitive. Free cysteine residues form intermolecular disulfides on top of that, producing dimers at roughly double the parent mass.
Deamidation is the second. Asparagine and glutamine side chains hydrolyse to aspartate and glutamate with a +1 Da shift, and the protein chemistry literature identifies Asn-Gly as the most labile motif because of the cyclic succinimide intermediate. A single dalton is easy to miss on a low-resolution spectrum and can still change charge state and binding behaviour in an assay.
Add backbone hydrolysis, reported as preferential at Asp-Pro bonds. Add pyroglutamate formation from an N-terminal glutamine, a 17 Da loss. Add physical aggregation, which removes active material from solution while changing no mass whatsoever.
Handling dominates the conversation once material arrives. Lyophilized powder kept cold, dry and dark holds up for long periods, while the same sequence in aqueous solution is typically stable for days to weeks depending on composition, and every freeze-thaw cycle adds stress. More usable material is often lost to a vial left on a bench over a weekend than to anything a synthesis chemist did wrong. This information is educational and applies to laboratory handling of research materials only; these compounds are supplied for research use and are not approved by the FDA for human use.
Peptide impurities types by origin: what each signal tells you
The table below maps the main peptide impurities types to where they come from, the test that detects them, and what each means at the bench.
| Impurity class | Where it comes from | How it is detected | Bottom line for the lab |
|---|---|---|---|
| Deletion and insertion sequences | A coupling that fails or repeats at a single SPPS cycle | RP-HPLC, often only a shoulder, confirmed by LC-MS mass difference | The closest structural analogue to the target, hardest to resolve chromatographically, and the most likely to behave unpredictably in an assay |
| Truncated sequences | Capped chains deliberately terminated early in synthesis | RP-HPLC, usually resolving earlier than the main peak | Easy to detect and easy to remove during preparative purification, so rarely the limiting problem in well-made material |
| Incomplete deprotection | Pbf, tBu or Trt groups surviving the acid cleavage step | LC-MS showing a fixed positive mass shift | Signals an under-optimised cleavage; ask to see the mass spectrum rather than the purity headline alone |
| Counterions (trifluoroacetate or acetate) | Ion-pairing modifier used during reversed-phase purification | Ion chromatography or 19F NMR for trifluoroacetate | Completely invisible to HPLC purity and the main reason net peptide content sits below the stated purity figure |
| Residual solvents | Acetonitrile, DMF, DCM and ether used in synthesis and purification | Headspace gas chromatography against ICH Q3C limits | A manufacturing hygiene indicator; Class 2 solvents carry defined limits and should never be assumed absent |
| Oxidation and deamidation products | Post-release exposure to oxygen, moisture and warm storage | LC-MS at +16 Da for oxidation or +1 Da for deamidation | Not a synthesis fault once material has shipped; controlled entirely by cold, dry, dark storage in the receiving lab |
What If: Reading Impurity Signals in Real Chromatograms
What if there is a small shoulder on the leading edge of my main peak?
Pull the LC-MS data before touching the gradient. A shoulder differing from the target by exactly one residue mass is a deletion sequence, while one showing zero mass difference is most likely an epimer or a beta-aspartyl rearrangement product from aspartimide formation. Both co-elute tightly because they are nearly identical molecules, so a shallower gradient or a different stationary phase chemistry is usually required to separate them at all.
What if LC-MS shows a satellite peak at +16 Da?
Treat it as oxidation until proven otherwise, most commonly methionine sulfoxide. A +16 Da shift corresponds to a single oxygen addition, and methionine, cysteine, tryptophan and histidine are the residues at risk. If the certificate of analysis for that lot showed a clean spectrum, the oxidation happened after release, which points at headspace oxygen, moisture ingress, or storage above the specified temperature.
What if two lots of the same peptide give different assay results?
Check net peptide content, counterion form and endotoxin before assuming a synthesis difference. Equal HPLC purity does not mean equal peptide mass per milligram, so two lots can deliver different actual quantities of peptide at the same weighed amount. Trifluoroacetate is also reported in the cell-culture literature to affect viability and assay readouts at sufficient concentrations, which is why acetate-exchanged material is specified for some cell work.
What if the powder looks like a sticky film rather than a fluffy cake?
Stop and check the moisture history of that vial. Lyophilized peptide is hygroscopic, and a collapsed or tacky cake generally means water uptake from a loose seal, a container opened while still cold, or a temperature excursion. Absorbed water accelerates hydrolysis, deamidation and aggregation, so cake appearance is a genuine quality signal rather than a cosmetic one.
The Unglamorous Truth About Peptide Impurities Types
Here is the honest answer: the headline purity percentage is the least informative number on most certificates. A 99% figure generated by peak-area integration at 214 nm describes peptide-related species and nothing else. It does not capture counterion load, water content, residual solvents or endotoxin, and those are precisely the variables that make two chemically identical lots behave differently in an experiment. The peptide impurities types that actually derail research are usually the ones that never appear as a peak. Read the mass spectrum, the water figure and the counterion form first. Read the purity headline last.
That data only helps when it is published, which is why Real Peptides posts lot-linked certificates of analysis covering third-party HPLC and mass spectrometry results for its small-batch material rather than a generic specimen document. Researchers comparing sequences across a study can review the full research peptide catalog, including well-characterised compounds such as BPC-157, all supplied strictly for laboratory research.
Peptide impurities types are, in the end, a record of process history. Every deletion sequence names a coupling that underperformed. Every trifluoroacetate ion names the purification method that made the material. Every +16 Da satellite names a storage lapse somewhere between the lyophiliser and the bench. That makes an impurity profile far more useful than a purity number, because a profile can be traced back to a cause and a cause can be corrected. The chromatogram is not a grade. It is a narrative of how the molecule was built and how it has been treated since.
Why do methionine, cysteine, and tryptophan residues oxidize, and how does oxidation show up on analysis?
Oxidation is the most common post-synthesis impurity class in sequences containing methionine, cysteine, tryptophan, or histidine. Methionine converts to methionine sulfoxide by adding a single oxygen atom, a mass increase of 16 Da. Tryptophan can pick up 16 or 32 Da, and free cysteine readily forms disulfide-linked dimers instead. The oxidant is usually ambient: dissolved oxygen in cleavage cocktails, peroxide traces in solvents, metal ions in water, or simple headspace air in a vial that has been opened repeatedly. Light accelerates tryptophan photo-oxidation, which is one reason amber glass and cold, dark holding conditions appear in most degradation prevention guidance and in cold chain documentation for resellers.
On reversed phase HPLC, sulfoxides are more polar than the parent and elute earlier, often as a shoulder a minute or two ahead of the main peak. Mass spectrometry confirms the assignment because the +16 Da shift is unambiguous against the calculated molecular weight of the intact chain. Oxidation does not break the amide backbone, so the chromatogram still looks like one compound family. Specifications commonly cap any single oxidized species at 0.5 to 1.0 percent.
What is deamidation, and why does a plus one dalton peak matter?
Deamidation is the hydrolysis of an asparagine or glutamine side chain amide into a carboxylic acid, converting Asn to Asp or isoAsp and Gln to Glu. The mass change is only +0.98 Da, which makes it one of the harder impurities to see without good instrumentation. Rate depends heavily on the residue that follows: Asn-Gly and Asn-Ser motifs deamidate fastest, and alkaline pH plus elevated temperature during storage in solution accelerate the reaction dramatically. Lyophilized solids deamidate far more slowly than solutions, which is why dry storage dominates the handling advice in most degradation prevention protocols.
Detection requires either high resolution MS, which resolves the roughly one dalton shift against the theoretical molecular weight, or a shallow reversed phase gradient that separates the deamidated and isoaspartyl forms as early eluting satellites. Standard quality control gradients frequently merge them into the main peak, which is part of why a reported number on a certificate needs context before it means anything; the distinction between 98 and 99 percent purity often lives inside those satellites. Typical limits sit near 1.0 percent for any single deamidated species, and lot-level certificates from Real Peptides are published at /coas/.
Which sequences are prone to aspartimide formation, and where in synthesis does it happen?
Aspartimide formation is a cyclization of an aspartic acid side chain onto the backbone nitrogen of the following residue, producing a five membered succinimide ring and a loss of 18 Da. It occurs during Fmoc solid phase synthesis, specifically during the repeated piperidine deprotection steps, so it accumulates with every cycle that follows the vulnerable aspartic acid. Asp-Gly is the classic high risk motif, with Asp-Ser, Asp-Asn, Asp-Ala, and Asp-Arg also susceptible. The ring then opens, producing a mixture of alpha and beta linked aspartyl peptides plus D-isomers, so a single side reaction can generate four related species.
Because the hydrolyzed products differ from the target by zero net mass in some cases, HPLC retention shifts are often the only clue, which is why method development at the contract manufacturing stage matters more than any downstream check. Mitigation includes modified base cocktails, backbone protection on the residue following aspartic acid, and shortened deprotection times. Buyers reviewing a manufacturer can ask whether such measures were used for sequences containing these motifs, and should confirm the target identity against standard peptide nomenclature before comparing any purity figure.
How does racemization happen during coupling, and how are D-amino acids measured?
Racemization converts an L-amino acid to its D-enantiomer through base mediated loss of the alpha proton, usually during activation and coupling. Cysteine and histidine are the most prone residues, followed by serine and phenylglycine-like analogues. Excess base, prolonged activation before the amine is available, and certain coupling reagents all raise the level. Fragment condensation, where protected segments are joined rather than built residue by residue, is especially vulnerable because the activated carbonyl sits next to a full stereocenter. The result is a diastereomer of the target with an identical mass, so mass spectrometry alone cannot see it; the amide backbone and the calculated molecular weight are unchanged.
Detection relies on chromatography. Shallow reversed phase gradients can resolve single-site diastereomers as a close eluting pair, and chiral analysis after total acid hydrolysis quantifies total D content per residue. The latter is a separate test and adds to manufacturing cost, so it is more often performed on complex or long sequences than on routine short ones. Common specification language caps total D-isomer content at roughly 1.0 percent, and buyers sourcing from any bulk supplier should check whether chiral testing was run at all.
What residual solvents remain after synthesis, and what limits apply to them?
Solid phase synthesis and purification leave solvent traces that survive lyophilization. The usual suspects are DMF, NMP, dichloromethane, diethyl ether, acetonitrile, methanol, and piperidine residues from deprotection. DMF and NMP are high boiling and bind to the solid, so they persist in the cake long after lower boiling solvents have gone. Acetonitrile arrives later, during reversed phase purification, and is the most common residual from the mobile phase. Scavengers used in cleavage cocktails, including triisopropylsilane and thioanisole, can also carry through.
Analysis is by headspace gas chromatography, usually with flame ionization or MS detection, since these volatiles do not appear at all in a UV chromatogram. ICH style classification sorts solvents into categories with limits generally expressed in parts per million, and the controlled solvents such as dichloromethane sit far lower than acetonitrile or ethanol. These values belong on the certificate alongside water content and counterion data, not buried in a manufacturing record. Residual solvent also influences how a lyophilized solid behaves during solvent selection. Documentation practices vary by facility, so contract manufacturing arrangements and testing scopes among United States manufacturers are worth comparing alongside endotoxin limits.
How much residual TFA is typical, and does the counterion count as an impurity?
Trifluoroacetic acid is used in cleavage and as the ion pairing agent in reversed phase purification, so a peptide that has not been salt exchanged arrives as a TFA salt. Residual TFA is commonly reported anywhere from a few percent to well over ten percent by mass in unexchanged material, and it scales with the number of basic residues since each arginine, lysine, and histidine can carry a counterion. That mass is real and it displaces peptide, which is the mechanism behind the gap between chromatographic purity and net peptide content.
Whether TFA is an impurity depends on the specification. It is not a sequence related impurity, but it is a quantified component and should be stated, not implied. Quantitation uses ion chromatography, fluorine NMR, or dedicated HPLC methods. Acetate exchange reduces TFA to low levels and is a documented option discussed in detail under counterions and salt forms. Exchange adds processing steps and affects wholesale pricing structure, so it is usually specified at order rather than assumed. Comparing lots without checking counterion identity makes a 98 versus 99 percent comparison meaningless, as does comparing figures across different suppliers.
What HPLC conditions are needed to resolve closely related peptide impurities?
Default quality control gradients are built for speed, not for separating a target from its own near neighbors. A twenty minute run from 5 to 95 percent organic will push deletion sequences, deamidated forms, and single-site diastereomers into the leading and trailing edges of the main peak, and integration then counts them as product. Resolving them generally requires a shallow gradient, often one to two percent change in organic per minute across the window where the target elutes, a sub two micron or core shell column, and controlled column temperature, since selectivity for diastereomers is temperature sensitive.
Detection wavelength matters too. Monitoring at 214 nm sees the amide bond and therefore every peptide-related species, while 280 nm only sees aromatic residues and will underreport impurities lacking tryptophan or tyrosine. A certificate that reports purity without stating gradient, column, wavelength, and run time is reporting a number without a method, which is a reasonable thing to ask about when evaluating whether a supplier is legitimate. The same question separates substantive supplier reviews from marketing copy and explains why the 98 versus 99 percent distinction is method dependent.
How does mass spectrometry distinguish one impurity class from another?
Mass spectrometry assigns identity by mass difference, and each impurity class has a characteristic signature. Oxidation adds 16 or 32 Da. Deamidation adds 0.98 Da. Aspartimide formation subtracts 18 Da. Deletion sequences subtract the residue mass of whatever is missing, so a lost glycine reads as minus 57 Da and a lost tryptophan as minus 186 Da. Incomplete side chain deprotection leaves tert-butyl at plus 56 Da or Pbf at plus 252 Da. Acetylation from capping steps adds 42 Da. Reading these against the theoretical molecular weight of the target turns a chromatogram into a diagnosis.
Two limits apply. Racemization produces no mass change at all, so MS is blind to it. And low resolution instruments cannot separate a plus one dalton deamidation from the natural isotope envelope, which is why high resolution or MS/MS sequencing is needed to localize the modification to a specific residue. Verifying that the reported mass actually corresponds to the named sequence also requires correct nomenclature, since analogue naming is inconsistent across vendors. Real Peptides supplies research use only compounds and publishes lot-level certificates at /coas/; MS scope varies by facility, so confirm it at the contract manufacturing stage.
How do storage conditions change which impurity dominates over time?
Impurity profiles are not static, and the dominant species shifts with conditions. A lyophilized solid held cold and dry changes slowly, with oxidation of methionine and tryptophan the most likely slow drift because residual headspace oxygen is still present. Once a solid takes up moisture, hydrolytic pathways open: deamidation at Asn-Gly sites, aspartimide ring opening, and backbone cleavage at acid labile Asp-Pro junctions. Elevated temperature accelerates all of these, and repeated warming and cooling cycles are worse than a single stable temperature because condensation adds water each time.
This is why a certificate describes a lot at the moment of testing and not indefinitely. Re-testing after extended holding is the only way to know the current profile. Practical controls include sealed amber vials, desiccant, minimal headspace, and consistent cold holding, all covered in standard degradation prevention methods and in the handling expectations placed on cold chain resellers. Transport is the weakest link, since shipments in transit experience the widest temperature swings; the same logic drives packing guidance for travel kits. Buyers working through distributors should confirm who holds the material, at what temperature, and for how long before it ships.
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add vials.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA